Oral formulation of methylglyoxal and its imino acid conjugates for human use
US6596755B2 · kind B2 · utility
5Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 1, 2002 |
| Grant date | Jul 22, 2003 |
| Priority date | — |
| Expiry date | Jul 1, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/542
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to an oral formulation of methylglyoxal and/or its imino acid conjugates for human use and methods for preparing the compositions. Particularly, the invention relates to compositions comprising methylglyoxal and more particularly, imino acid conjugates of methylglyoxal. The present invention also relates to formulations of methylglyoxal and imino acid conjugates of methylglyoxal that can be used for the treatment and suppression of malignant diseases including but not limited to the cancers of Colon, Prostate, Pancreas, Lung, Oral cavity, Glioblastoma, and Leukemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.